Contrasting Co-Diagnostics (NASDAQ:CODX) and CVR Medical (OTCMKTS:CRRVF)

CVR Medical (OTCMKTS:CRRVF) and Co-Diagnostics (NASDAQ:CODX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Earnings & Valuation

This table compares CVR Medical and Co-Diagnostics”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVR Medical	N/A	N/A	N/A	N/A	N/A
Co-Diagnostics	$6.81 million	3.20	-$35.33 million	($1.38)	-0.49

CVR Medical has higher earnings, but lower revenue than Co-Diagnostics.

Institutional and Insider Ownership

15.0% of Co-Diagnostics shares are owned by institutional investors. 6.1% of Co-Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Volatility & Risk

CVR Medical has a beta of 22.67, suggesting that its share price is 2,167% more volatile than the S&P 500. Comparatively, Co-Diagnostics has a beta of -0.63, suggesting that its share price is 163% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and recommmendations for CVR Medical and Co-Diagnostics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVR Medical	0	0	0	0	0.00
Co-Diagnostics	0	1	0	0	2.00

Co-Diagnostics has a consensus price target of $1.50, indicating a potential upside of 119.62%. Given Co-Diagnostics’ stronger consensus rating and higher probable upside, analysts plainly believe Co-Diagnostics is more favorable than CVR Medical.

Profitability

This table compares CVR Medical and Co-Diagnostics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CVR Medical	N/A	N/A	N/A
Co-Diagnostics	-563.93%	-54.94%	-49.28%

Summary

Co-Diagnostics beats CVR Medical on 5 of the 9 factors compared between the two stocks.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.

About Co-Diagnostics

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.